Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 6.70
+0.36 (5.68%)
Aug 22, 2025, 5:39 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €187.60 million as of August 22, 2025. Its market cap has increased by 1.21% in one year.
Market Cap
187.60M
Enterprise Value
165.27M
Revenue
9.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.70
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 187.60M, a decrease of -23.33%. That is a compound annual growth rate of -5.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 187.60M | 2.45% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 37.09B |
| argenx SE | 34.47B |
| Financière de Tubize | 7.05B |
| Fagron NV | 1.52B |
| Ion Beam Applications | 357.64M |
| Onward Medical | 224.57M |
| Nyxoah | 203.65M |
| Sequana Medical NV | 60.40M |